TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3162058

Group type: EXPERIMENTAL
Intervention: Blood-sugar lowering sulfonylureas (group II)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Insulin-dependent treatment (group III)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diet only (group I)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diet and blood-sugar lowering sulfonylureas (group II)
Number of subjects: 60
Study: 31303149

Group type: EXPERIMENTAL
Intervention: HIV risk reduction intervention, the Holistic Health Recovery Program for Malaysia (HHRP‐M)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: pre‐release methadone initiation
Number of subjects: 296

Group type: COMPARATOR
Intervention: standard care
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: forced relocation outside Kuala Lumpur after prison release
Number of subjects: 296
Study: 27856954

Group type: EXPERIMENTAL
Intervention: Surface cooling to 34.0°C
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Surface cooling to 34.5°C
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Surface cooling to 35.0°C
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 22
Study: 25338680

Group type: EXPERIMENTAL
Intervention: Lilac LAB (Bacillus coagulans lilac‐01, 1 × 10(8) CFU)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Placebo (okara powder, 2 g/d)
Number of subjects: 297
Study: 24136378

Group type: EXPERIMENTAL
Intervention: Low-dose remifentanil (0.1 μg kg min) and preoperative isotonic saline (n=15)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-dose remifentanil (0.2 μg kg min, increased to clinical demand) and preoperative saline (n=17)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-dose remifentanil (0.2 μg kg min, increased to clinical demand) and preoperative amantadine (200 mg/500 ml) (n=16)
Number of subjects: 60
Study: 21843831

Group type: EXPERIMENTAL
Intervention: Localized application of vibration (3 sessions per week for 8 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (usual daily activities)
Number of subjects: 30
Study: 20079178

Group type: EXPERIMENTAL
Intervention: Intervention group (546 patients)
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Nonintervention group (516 patients)
Number of subjects: 1062

Group type: EXPERIMENTAL
Intervention: Extremely high risk subgroup (19 patients)
Number of subjects: 1062

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and nonintervention)
Number of subjects: 1062
Study: 17576513

Group type: EXPERIMENTAL
Intervention: Handholding
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Walker
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Guarding
Number of subjects: 21
Study: 15310314

Group type: EXPERIMENTAL
Intervention: 30% fructose solution (0.5 mL)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 30% glucose solution (0.5 mL)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (sterile water, 0.5 mL)
Number of subjects: 34
Study: 11669411

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg and then 8 mg daily)
Number of subjects: 12236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12236
Study: 9543561

Group type: EXPERIMENTAL
Intervention: Piroxicam-beta-cyclodextrin (PBCD)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Slow release diclofenac (DCL)
Number of subjects: 107
Study: 8149571

Group type: EXPERIMENTAL
Intervention: Disinfection solutions (three different systems)
Number of subjects: 44
Study: 3146553

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin 10 mg/24 hours
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31309323

Group type: EXPERIMENTAL
Intervention: Preoperative oral carbohydrate supplementation (CHO)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Preoperative fasting (FAST)
Number of subjects: 50
Study: 28592751

Group type: COMPARATOR
Intervention: Combination therapy (atorvastatin 10‐20 mg and ezetimibe 10 mg/day; Group C)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Statin monotherapy (atorvastatin 10‐20 mg; Group M)
Number of subjects: 131
Study: 24621985

Group type: EXPERIMENTAL
Intervention: AT/RT3 (Aerobic Training + Resistance Training, 3 sets)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: AT/RT1 (Aerobic Training + Resistance Training, 1 set)
Number of subjects: 72

Group type: COMPARATOR
Intervention: AT (Aerobic Training alone)
Number of subjects: 72
Study: 23474003

Group type: EXPERIMENTAL
Intervention: BreatheMAX device (humidification and oscillation of inspired air)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham intervention (no humidification and oscillation)
Number of subjects: 15
Study: 21439049

Group type: EXPERIMENTAL
Intervention: Parental support programme including health information brochure, motivational interviewing sessions, and teacher-led activities.
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control group (no parental support programme).
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Parental support programme.
Number of subjects: 242
Study: 20084878

Group type: EXPERIMENTAL
Intervention: Freeze-dried live attenuated varicella vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified what control was used)
Number of subjects: 0
Study: 16425096

Group type: EXPERIMENTAL
Intervention: Sunscreen use during workdays
Number of subjects: 2660

Group type: EXPERIMENTAL
Intervention: Sunscreen use during non-working days
Number of subjects: 2660

Group type: EXPERIMENTAL
Intervention: Widebrim hat use during workdays
Number of subjects: 2660

Group type: EXPERIMENTAL
Intervention: Widebrim hat use during non-working days
Number of subjects: 2660
Study: 15461825

Group type: EXPERIMENTAL
Intervention: Morphine 0.2 mg/kg IV
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 14606018

Group type: EXPERIMENTAL
Intervention: Absence of rugae in the gastric corpus
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Presence of visible vessels in the gastric corpus
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Presence of visible vessels in the antrum
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Endoscopic features (alone or in combination)
Number of subjects: 488
Study: 11189671

Group type: EXPERIMENTAL
Intervention: Weekly 2-hour visit and walk by volunteers for 9 months (experimental group)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (waiting list for 6 weeks)
Number of subjects: 21
Study: 8956701

Group type: EXPERIMENTAL
Intervention: Cafetière coffee
Number of subjects: 46

Group type: COMPARATOR
Intervention: Filtered coffee
Number of subjects: 46
Study: 1579647

Group type: EXPERIMENTAL
Intervention: Instruction in personal control over noise via the availability of a sound conditioner
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: No instruction in personal control over noise
Number of subjects: 105

Group type: COMPARATOR
Intervention: Quiet conditions
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: CCU sounds
Number of subjects: 105
Study: 2865292

Group type: COMPARATOR
Intervention: Cephazolin (1 g)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Cefotetan (1 g)
Number of subjects: 168
Study: 30597582

Group type: EXPERIMENTAL
Intervention: Self-Awareness condition
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Peer (other-awareness) condition
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 121
Study: 29235555

Group type: EXPERIMENTAL
Intervention: Whole grain brown rice
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-amylose brown rice
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-amylose brown rice
Number of subjects: 10

Group type: COMPARATOR
Intervention: White rice
Number of subjects: 10
Study: 27495071

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Coaching (CBC) program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 24842541

Group type: EXPERIMENTAL
Intervention: Healing ceremony
Number of subjects: 25
Study: 21448709

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (vitamin C) 2 g during myomectomy
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (myomectomy without interventions)
Number of subjects: 102
Study: 19747888

Group type: EXPERIMENTAL
Intervention: FOBT
Number of subjects: 9889

Group type: COMPARATOR
Intervention: OC
Number of subjects: 9889
Study: 18767509

Group type: EXPERIMENTAL
Intervention: Zinc oxide-eugenol (ZOE)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Calcium hydroxide/iodoform paste (Vitapex)
Number of subjects: 42
Study: 15975312

Group type: EXPERIMENTAL
Intervention: Shengxueling (SXL)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 86
Study: 12708881

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering with perindopril 2mg/indapamide 0.625 mg then perindopril 4 mg/indapamide 1.25mg
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Intensive sulphonylurea‐based glucose control regimen (target HbA(1c) </= 6.5%)
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Usual guidelines‐based therapy
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Matching placebo for blood pressure lowering
Number of subjects: 10000
Study: 9885791

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (subanesthetic doses)
Number of subjects: 15
Study: 8574629

Group type: EXPERIMENTAL
Intervention: Paget's disease patients managed in a rheumatology department
Number of subjects: 700

Group type: COMPARATOR
Intervention: Intravenous urograms in urology department patients
Number of subjects: 700
Study: 1960829

Group type: EXPERIMENTAL
Intervention: 8.0 km/h group (aerobic walkers)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 6.4 km/h group (brisk walkers)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 4.8 km/h group (strollers)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Sedentary controls
Number of subjects: 102
Study: 7128954

Group type: EXPERIMENTAL
Intervention: Keto analogs of branched-chain amino acids (15.24 g orally over 4 weeks)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (oral)
Number of subjects: 12
Study: 31534016

Group type: EXPERIMENTAL
Intervention: HVTN 097 vaccine regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: RV144 vaccine regimen
Number of subjects: 0
Study: 28369286

Group type: COMPARATOR
Intervention: D+Ex- (Vitamin D + Exercise)
Number of subjects: 409

Group type: COMPARATOR
Intervention: D-Ex+ (Vitamin D + No Exercise)
Number of subjects: 409

Group type: COMPARATOR
Intervention: D+Ex+ (Vitamin D + Exercise)
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Exercise groups (D+Ex- and D-Ex+)
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 409
Study: 26374467

Group type: EXPERIMENTAL
Intervention: 14‐Fr silicone tubing with balloon
Number of subjects: 284

Group type: COMPARATOR
Intervention: 14‐Fr silicone tubing without balloon
Number of subjects: 284
Study: 23907810

Group type: EXPERIMENTAL
Intervention: AZD3199 (480 µg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: AZD3199 (1920 µg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Formoterol (36 µg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: AZD3199 (480 µg) and 1920 µg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: AZD3199
Number of subjects: 37

Group type: COMPARATOR
Intervention: Formoterol
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: AZD3199 and Formoterol
Number of subjects: 37
Study: 21543191

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT) with Rehacom® software, n=8
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (non-CRT), n=9
Number of subjects: 17
Study: 20082253

Group type: EXPERIMENTAL
Intervention: Gubitong Recipe (GBT) Decoction, one dose every day for eight weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Glucosamine sulfate 500 mg thrice a day for eight weeks (Control)
Number of subjects: 90
Study: 16914458

Group type: EXPERIMENTAL
Intervention: Joint crisis plan
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standardised service information
Number of subjects: 160
Study: 15624743

Group type: EXPERIMENTAL
Intervention: LED photomodulation using the Gentlewaves full panel 590 nm high energy LED array with a specific sequence or code of pulsing in the millisecond domain
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: LED photomodulation
Number of subjects: 93
Study: 11180037

Group type: EXPERIMENTAL
Intervention: 150 mg of fluvoxamine per day for 5 days
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 75 mg of fluvoxamine per day for 5 days
Number of subjects: 14
Study: 9735531

Group type: EXPERIMENTAL
Intervention: Wearing ambient lenses
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 18
Study: 7986789

Group type: EXPERIMENTAL
Intervention: Raw frozen, blanched or canned carrots (15 g dietary fibre/d)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Raw or raw frozen carrots (15 g dietary fibre/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control periods (low-fibre basal diet)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Experimental periods (carrot consumption)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both types of carrot (raw and processed)
Number of subjects: 24
Study: 2607285

Group type: EXPERIMENTAL
Intervention: IRM
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: EBA cement
Number of subjects: 51

Group type: COMPARATOR
Intervention: Amalgam with Copalite
Number of subjects: 51

Group type: COMPARATOR
Intervention: Negative controls
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: IRM vs EBA cement
Number of subjects: 51
Study: 4717846

Group type: EXPERIMENTAL
Intervention: Lincomycin
Number of subjects: 60
Study: 7353190

Group type: EXPERIMENTAL
Intervention: Metoclopramide 20 mg by mouth
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 31109252

Group type: EXPERIMENTAL
Intervention: Children with ASD and elevated anxiety symptoms
Number of subjects: 93
Study: 30139293

Group type: EXPERIMENTAL
Intervention: SIT-STAND (alternating sitting and standing every 30 minutes)
Number of subjects: 25

Group type: COMPARATOR
Intervention: SIT (prolonged sitting)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: SIT-STAND
Number of subjects: 25

Group type: COMPARATOR
Intervention: SIT
Number of subjects: 25
Study: 26800856

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS over the contralesional PMd (900 pulses at 110% of the motor threshold)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham rTMS (900 pulses at 0% of the motor threshold)
Number of subjects: 10
Study: 23800393

Group type: EXPERIMENTAL
Intervention: Cooling for 72 hours
Number of subjects: 314

Group type: COMPARATOR
Intervention: Standard care without cooling
Number of subjects: 314
Study: 22318965

Group type: EXPERIMENTAL
Intervention: Trophic enteral feeds
Number of subjects: 185

Group type: COMPARATOR
Intervention: Full-energy feeds
Number of subjects: 185
Study: 19469604

Group type: EXPERIMENTAL
Intervention: Self-determined motivation at the end of CR
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Psychological need satisfaction for competence
Number of subjects: 68
Study: 17150279

Group type: EXPERIMENTAL
Intervention: CTLA4 haplotypes in men with self-limited and chronic infection
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: CTLA4 haplotypes in male end-of-treatment responders
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: CTLA4 polymorphisms
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Interferon-alpha monotherapy or infection with HCV genotypes 1/4
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 1274
Study: 15022578

Group type: EXPERIMENTAL
Intervention: Alcoholic liver disease
Number of subjects: 50
Study: 10636270

Group type: EXPERIMENTAL
Intervention: Stable positive T waves (group 1, n = 35)
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Decrease > or =1 in negative T waves (group 2, n = 361)
Number of subjects: 536

Group type: COMPARATOR
Intervention: No change in negative T waves (group 3, n = 64)
Number of subjects: 536

Group type: COMPARATOR
Intervention: Increase > or =1 in negative T waves (group 4, n = 76)
Number of subjects: 536
Study: 8884559

Group type: EXPERIMENTAL
Intervention: cilazapril (5-10 mg/day)
Number of subjects: 66

Group type: COMPARATOR
Intervention: nifedipine (20-40 mg slow-release three times a day)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: cilazapril (5-10 mg/day) in diabetic patients
Number of subjects: 66
Study: 1304463

Group type: EXPERIMENTAL
Intervention: CEE3 (2 mg orally every 2 weeks)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 3982576

Group type: EXPERIMENTAL
Intervention: 1 alpha-OH-vitamin D3 (1 microgram/day initially, 0.3 microgram/day after 6 months)
Number of subjects: 27

Group type: COMPARATOR
Intervention: High doses of calcium carbonate (mean 9 +/- 5 g/day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (same treatment as before)
Number of subjects: 27
Study: 31004370

Group type: EXPERIMENTAL
Intervention: Healthcare costs for diabetic foot ulceration and amputation in diabetes in 2014-2015
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ulceration care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Care in community, outpatient and primary settings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Length of stay for inpatients with ulceration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reduction of diabetic foot ulcers prevalence
Number of subjects: 0
Study: 28671097

Group type: EXPERIMENTAL
Intervention: Desloratadine Citrate Disodium
Number of subjects: 100

Group type: COMPARATOR
Intervention: Mizolastine
Number of subjects: 100
Study: 25558030

Group type: EXPERIMENTAL
Intervention: Abdominal massage (15-minute gentle abdominal massage, administered twice daily for 3 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (twice-daily 15-minute social interaction contact with the same nurse)
Number of subjects: 80
Study: 23667615

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (fluticasone) for 30 months
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo for 30 months
Number of subjects: 64

Group type: COMPARATOR
Intervention: Current smokers vs ex-smokers
Number of subjects: 64
Study: 21864817

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent (ZES)
Number of subjects: 2332

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 2332
Study: 19755551

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shockwave treatment: one session weekly for four to six weeks
Number of subjects: 104

Group type: COMPARATOR
Intervention: Supervised exercises: two 45 minute sessions weekly for up to 12 weeks
Number of subjects: 104
Study: 17341003

Group type: EXPERIMENTAL
Intervention: EGb 761
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 14756388

Group type: COMPARATOR
Intervention: Perfalgan 1 g
Number of subjects: 24

Group type: COMPARATOR
Intervention: Propacetamol 2 g
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Perfalgan 0.5 g
Number of subjects: 24
Study: 11318774

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (1200 microg dose)
Number of subjects: 8
Study: 9227301

Group type: EXPERIMENTAL
Intervention: VVI pacing
Number of subjects: 30

Group type: COMPARATOR
Intervention: DDI pacing
Number of subjects: 30
Study: 8482617

Group type: EXPERIMENTAL
Intervention: Annular phased array applicator (60-80 MHz)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sigma applicator (70-90 MHz)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 18
Study: 3546936

Group type: EXPERIMENTAL
Intervention: Pulsed Doppler spectrum analysis measuring peak systolic frequency (PSF)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: PSF of 4.5 kHz
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: PSF of 5.0 kHz
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Linear regression analysis of PSF
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Nonlinear regression analysis of PSF
Number of subjects: 242
Study: 31595830

Group type: EXPERIMENTAL
Intervention: Imagining social scenarios with positive outcomes
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Imagining social scenarios with negative outcomes
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Imagining non-social scenarios with positive outcomes
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Imagining non-social scenarios with negative outcomes
Number of subjects: 197
Study: 30962136

Group type: EXPERIMENTAL
Intervention: Laparoscopic liver resection
Number of subjects: 136

Group type: COMPARATOR
Intervention: Open liver resection
Number of subjects: 136
Study: 28639542

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate MDPI (100 or 200 μg)
Number of subjects: 728

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol MDPI (100 μg/12.5 μg or 200 μg/12.5 μg)
Number of subjects: 728

Group type: COMPARATOR
Intervention: Placebo MDPI
Number of subjects: 728

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol MDPI (100 μg/12.5 μg)
Number of subjects: 728
Study: 26520220

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Anxiety Management (Control)
Number of subjects: 30
Study: 22766525

Group type: EXPERIMENTAL
Intervention: Budesonide 9 mg
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Budesonide 15 mg
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 21729145

Group type: EXPERIMENTAL
Intervention: FSC‐treated T‐shirts (28 pieces for 4 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non‐treated T‐shirts
Number of subjects: 40
Study: 19546756

Group type: EXPERIMENTAL
Intervention: Betamethasone (repeat courses)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Betamethasone (at least four repeat courses)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Betamethasone (1-3 repeat courses)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study: 17127775

Group type: EXPERIMENTAL
Intervention: PriorixA
Number of subjects: 60

Group type: COMPARATOR
Intervention: M-M-R IIA
Number of subjects: 60
Study: 15580380

Group type: EXPERIMENTAL
Intervention: Residents (Postgraduate year two)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Attending surgeons
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Residents and attending surgeons
Number of subjects: 152